艾昂尼斯制药 IONS
$39.42 +$0.62 (+1.60%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $39.20 -0.56%
开盘$39.02
昨收$38.80
当日区间$38.53 – $40.00
成交量2.91M
市值$6.55B
市盈率（TTM）–
股息率–
IONS 相关新闻
匹配 Ionis Pharmaceuticals 或代码 IONS 的头条新闻，按最新排序。
- A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $84 to $104
- A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $61 to $115
- CCORF Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $95
- BMO Capital Downgrades Ionis Pharmaceuticals(IONS.US) to Hold Rating, Cuts Target Price to $61 负面
- H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $115
- CCORF Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $85
- Oppenheimer Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $85 负面
- H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $100
- BMO Capital Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $54 负面
- A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $84 to $100
- A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $70 to $100
- Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE) and Ionis Pharmaceuticals (IONS)
- J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $70 负面
- Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $85
- Guggenheim Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $80 负面
暂无评论——快来第一个聊聊 IONS。
登录后参与讨论。